The serious consequences of the global coronavirus disease 2019 (COVID-19) pandemic
have prompted a rapid global response to develop effective therapies that can lessen …

Severe cases of COVID-19 infection, often leading to death, have been associated with
variants of acute respiratory distress syndrome (ARDS). Cell therapy with mesenchymal …

The severe respiratory consequences of the coronavirus disease 2019 (COVID-19)
pandemic have prompted the urgent need for novel therapies. Cell-based therapies …

Since it was first reported, the novel coronavirus disease 2019 (COVID-19) remains an
unresolved puzzle for biomedical researchers in different fields. Various treatments, drugs …

The severe respiratory consequences of the coronavirus disease 2019 (COVID-19)
pandemic have prompted urgent need for novel therapies. Cell-based approaches, primarily …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-caused coronavirus
disease 2019 (COVID-19) pandemic has become a global health crisis with an extremely …

Patients with severe COVID-19 experience cytokine storm, an uncontrolled upregulation of
pro-inflammatory cytokines, which if unresolved leads to acute respiratory distress syndrome …

MSC (aka mesenchymal stem cell or medicinal signaling cell) cell therapies show promise
in decreasing mortality in acute respiratory distress syndrome (ARDS) and suggest benefits …

The global COVID-19 pandemic has prompted urgent need for potential therapies for severe
respiratory consequences resulting from coronavirus infection. New therapeutic agents that …

The mortality rate of critically ill patients with acute respiratory distress syndrome (ARDS) is
30.9% to 46.1%. The emergence of the coronavirus disease 2019 (Covid-19) has become a …